Fuelling Ontario’s Next Generation of Biotech Spinouts
Ontario Genomics is launching our Regional Genomic Applications Partnership Program (GAPP) to accelerate the commercialization of academic discoveries into made-in-Ontario biotech solutions.
Ontario is home to world-class researchers and institutions producing groundbreaking discoveries, yet many of them fail to progress beyond the lab. That’s because spinout companies (formed to commercialize academic intellectual property) that bring these innovations to market are often stifled by insufficient access to capital, long commercialization timelines and limited business expertise.
Thanks in part to a four year, $4 million commitment from Genome Canada, Ontario Genomics’ Regional GAPP is addressing these challenges by supporting spinouts at this critical lab-to-company technology transfer stage, facilitating R&D capacity, independence from academia and positioning them for seed financing. The end results will fuel job creation, company retention, IP generation and attract foreign investment, while reinforcing Ontario’s economic resilience and global reputation in genomics innovation.
Eligibility Criteria:
- Your spinout company is incorporated in Canada and based in Ontario
- Your spinout can commit $222,578 cash or in-kind over the two years of the program
- Your technology is genomics or biotech enabled
- Your spinout company is partnered with an Ontario-based researcher
- Your company has at least two people (if the lead project researcher is also the CEO, the company’s governance board must have at least one additional member)
If you meet the above criteria, please visit the program page and fill out the intake form by Oct 24th.
